Abstract
Hypoxia is a common symptom of many serious disorders, including cancer, ischemic strokes, and rheumatoid arthritis. It is a natural physiologic barrier seen in the microenvironment of solid tumors that has significantly restricted the therapeutic impact of photodynamic treatment (PDT). For oxygen-consumption photodynamic treatment (PDT), local hypoxia is an unfavorable obstacle in tumors. Angiogenesis, invasion, metastasis, and chemotherapy resistance are all affected by a shortage of oxygen. Furthermore, PDT has the possibility of aggravating hypoxia. Meanwhile, the troublesome aggregation-caused quenching effect affects the photosensitizer (PS) compounds utilized in PDT applications and dramatically reduces the efficiency with which deadly reactive oxygen species are produced. Over recent decades, hypoxia's potential as a therapeutic target has become more widely recognized. Because of their benefits in safety, target specificity, and tumor penetrability, peptides have been intensively explored to treat these disease conditions. Low drug/energy delivery effectiveness, drug resistance brought on by hypoxia, and tumor nonspecificity can all be mitigated using peptides. Three basic methods have recently been applied to use peptide-based nanomaterials to target hypoxia: (i) using hypoxic microenvironment-sensitive peptide linkers that could be split to liberate medicinal payloads; (ii) the merger foregoing, in which earmarks peptides to direct the system to hypoxic surroundings, allowing for selective cleavage; and (iii) target cellular environments using peptide ligands that are particular for a hypoxic environment, such as receptors of the cell surface that are upregulated. In this paper, we go over the advantages and limitations of using peptide-based hypoxia-targeting nanomaterials in a variety of therapeutic situations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- PEG:
-
Polyethylene Glycol
- H2O2:
-
Hydrogen Peroxide
- DOX:
-
Doxorubicin
- CC:
-
Cytochrome
- O2:
-
Oxygen
- SR:
-
Singlet Oxygen Responsive
- AVT-NP:
-
Angiogenesis Vessel Targeting Nanoparticle
- TPC:
-
Tris Phenyl Chlorine
- TG2:
-
Transglutaminase
- ELPs:
-
Elastin-Like polypeptides
- PLA:
-
Polylactic Acid
- PGA:
-
Polyglycolic Acid
- PLGA:
-
Polylactic Acid Glycolic Acid
- PCL:
-
Polycaprolactone
- DA:
-
Dimethylmaleic Anhydride
- ROS:
-
Reactive Oxygen Species
- PFOB:
-
Perfluorooctyl Bromide
- HPAO:
-
Hydroxyphenyl Propionic Acid-OSu
- SPECT:
-
Single Photon Emission Computed Tomography
- NPs:
-
Nanoparticles
- DSPC:
-
Distearoyl-Sn Glycero-3-Phosphocholine
- POPE:
-
Palmitoyl Oleoyl phosphatidylethanolamine
- CRT:
-
Calreticulin
- EPR:
-
Enhanced Permeability and Retention
- NADs:
-
Nitrobenzyl Alcohol Derivatives
- PDT:
-
Photodynamic Therapy
- NI:
-
Nitro Imidazole
- AZR:
-
Azoreductase
- NA:
-
Nitrobenzyl Alcohol
- AZO:
-
Azobenzene
References
Ahmad Z, Lv S, Tang Z, Shah A, Chen X (2016) Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin. J Biomater Sci Polym Ed 27(1):40–54. https://doi.org/10.1080/09205063.2015.1107707
Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J Drug Target 27(7):742–761. https://doi.org/10.1080/1061186X.2018.1527337
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102.https://doi.org/10.1186/1556-276X-8-102
Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH (2002) Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 277(46):44236–44243. https://doi.org/10.1074/jbc.M207578200
Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941–951. https://doi.org/10.1038/nbt.3330
Boekhoven J, Stupp SI (2014) 25th anniversary article: supramolecular materials for regenerative medicine. Adv Mater (Deerfield Beach, Fla.) 26(11):1642–1659. https://doi.org/10.1002/adma.201304606
Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4(6):437–447. https://doi.org/10.1038/nrc1367
Canalle LA, Löwik DW, van Hest JC (2010) Polypeptide-polymer bioconjugates. Chem Soc Rev 39(1):329–353. https://doi.org/10.1039/b807871h
Cheng R, Liu L, Xiang Y, Lu Y, Deng L, Zhang H, Santos HA, Cui W (2020) Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications. Biomaterials 232:119706. https://doi.org/10.1016/j.biomaterials.2019.119706
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, De Falco S (2015) Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models. Oncotarget 6(12):10563–10576. https://doi.org/10.18632/oncotarget.3384
Dai Y, Wang B, Sun Z, Cheng J, Zhao H, Wu K, Sun P, Shen Q, Li M, Fan Q (2019) Multifunctional theranostic liposomes loaded with a hypoxia-activated prodrug for cascade-activated tumor selective combination therapy. ACS Appl Mater Interfaces 11(43):39410–39423. https://doi.org/10.1021/acsami.9b11080
Dehsorkhi A, Castelletto V, Hamley IW (2014) Self-assembling amphiphilic peptides. J Peptide Sci: an off Publication Eur Peptide Soc 20(7):453–467. https://doi.org/10.1002/psc.2633
Deng C, Wu J, Cheng R, Meng F, Klok HA, Zhong Z (2014) Functional polypeptide and hybrid materials: precision synthesis via α-amino acid N-carboxyanhydride polymerization and emerging biomedical applications. Prog Polym Sci 39(2):330–364. https://doi.org/10.1016/j.progpolymsci.2013.10.008
Deng J, Liu F, Wang L, An Y, Gao M, Wang Z, Zhao Y (2018) Hypoxia- and singlet oxygen-responsive chemo-photodynamic Micelles featured with glutathione depletion and aldehyde production. Biomater Sci 7(1):429–441. https://doi.org/10.1039/c8bm01042k
Deng L, Zhang F, Wu Y, Luo J, Mao X, Long L, Gou M, Yang L, Deng D (2019) RGD-modified nanocarrier-mediated targeted delivery of HIF-1α-AA plasmid DNA to cerebrovascular endothelial cells for ischemic stroke treatment. ACS Biomater Sci Eng 5(11):6254–6264. https://doi.org/10.1021/acsbiomaterials.9b01362
Dissanayake S, Denny WA, Gamage S, Sarojini V (2017) Recent developments in anticancer drug delivery using cell-penetrating and tumour targeting peptides. J Control Release: off J Control Release Soc 250:62–76. https://doi.org/10.1016/j.jconrel.2017.02.006
Dube N, Seo JW, Dong H, Shu JY, Lund R, Mahakian LM, Ferrara KW, Xu T (2014) Effect of alkyl length of peptide-polymer amphiphile on cargo encapsulation stability and pharmacokinetics of 3-helix micelles. Biomacromol 15(8):2963–2970. https://doi.org/10.1021/bm5005788
Elmes RB (2016) Bioreductive fluorescent imaging agents: applications to tumour hypoxia. Chem Commun (camb) 52(58):8935–8956. https://doi.org/10.1039/c6cc01037g
Ernsting MJ, Murakami M, Roy A, Li SD (2013) Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release: off J Control Release Soc 172(3):782–794. https://doi.org/10.1016/j.jconrel.2013.09.013
Fan Y, Lu M, Yu XA, He M, Zhang Y, Ma XN, Kou J, Yu BY, Tian J (2019) Targeted myocardial hypoxia imaging using a nitroreductase-activatable near-infrared fluorescent nanoprobe. Anal Chem 91(10):6585–6592. https://doi.org/10.1021/acs.analchem.9b00298
Feng Z, Wang H, Chen X, Xu B (2017) Self-assembling ability determines the activity of enzyme-instructed self-assembly for inhibiting cancer cells. J Am Chem Soc 139(43):15377–15384. https://doi.org/10.1021/jacs.7b07147
Ghalamfarsa G, Kazemi MH, Raoofi Mohseni S, Masjedi A, Hojjat-Farsangi M, Azizi G, Yousefi M, Jadidi-Niaragh F (2019) CD73 as a potential opportunity for cancer immunotherapy. Expert Opin Ther Targets 23(2):127–142.https://doi.org/10.1080/14728222.2019.1559829
Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G (2016) Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery. Bioorg Med Chem 24(2):294–303. https://doi.org/10.1016/j.bmc.2015.12.020
Gonzalez Gomez A. Hosseinidoust Z (2020) Liposomes for antibiotic encapsulation and delivery. ACS Infect Dis 6(5):896–908.https://doi.org/10.1021/acsinfecdis.9b00357
Guo D, Xu S, Wang N, Jiang H, Huang Y, Jin X, Xue B, Zhang C, Zhu X (2017) Prodrug-embedded angiogenic vessel-targeting nanoparticle: a positive feedback amplifier in hypoxia-induced chemo-photo therapy. Biomaterials 144:188–198. https://doi.org/10.1016/j.biomaterials.2017.08.032
Hajizadeh F, Moghadaszadeh Ardebili S, Baghi Moornani M, Masjedi A, Atyabi F, Kiani M, Namdar A, Karpisheh V, Izadi S, Baradaran B, Azizi G, Ghalamfarsa G, Sabz G, Yousefi M, Jadidi-Niaragh F (2020) Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol 882:173235.https://doi.org/10.1016/j.ejphar.2020.173235
Ihsanullah KM, Kumar BN, Zhao Y, Muhammad H, Liu Y, Wang L, Liu H, Jiang W (2020) Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy. Biomaterials 245:119982. https://doi.org/10.1016/j.biomaterials.2020.119982
Ikeda M, Kawakami M, Kitade Y (2015) Pro-apoptotic peptide amphiphile self-assembled with the assistance of polycations. Chem Lett 44(8):1137–1139. https://doi.org/10.1246/cl.150399
Kale AA, Torchilin VP (2007) “Smart” drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J Liposome Res 17(3–4):197–203. https://doi.org/10.1080/08982100701525035
Ko YT, Hartner WC, Kale A, Torchilin VP (2009) Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther 16(1):52–59. https://doi.org/10.1038/gt.2008.135
Kulkarni P, Haldar MK, Katti P, Dawes C, You S, Choi Y, Mallik S (2016) Hypoxia responsive, tumor penetrating lipid nanoparticles for delivery of chemotherapeutics to pancreatic cancer cell spheroids. Bioconjug Chem 27(8):1830–1838. https://doi.org/10.1021/acs.bioconjchem.6b00241
Kulkarni P, Haldar MK, Karandish F, Confeld M, Hossain R, Borowicz P, Gange K, Xia L, Sarkar K, Mallik S (2018) Tissue-penetrating, hypoxia-responsive echogenic polymersomes for drug delivery to solid tumors. Chemistry (weinheim an Der Bergstrasse, Germany) 24(48):12490–12494. https://doi.org/10.1002/chem.201802229
Laha B, Maiti S, Sen KK, Jana S (2019) Nanoscale polysaccharide-based particles for the delivery of therapeutic molecules. In: Green synthesis, characterization and applications of nanoparticles. Elsevier, pp 347–368. https://doi.org/10.1016/B978-0-08-102579-6.00014-9
Lee S, Trinh T, Yoo M, Shin J, Lee H, Kim J, Hwang E, Lim YB, Ryou C (2019) Self-assembling peptides and their application in the treatment of diseases. Int J Mol Sci 20(23):5850. https://doi.org/10.3390/ijms20235850
Li M, Lin F, Lin Y, Peng W (2015) Extracellular polysaccharide from Bordetella species reduces high glucose-induced macrophage apoptosis via regulating interaction between caveolin-1 and TLR4. Biochem Biophys Res Commun 466(4):748–754. https://doi.org/10.1016/j.bbrc.2015.09.125
Li J, Meng X, Deng J, Lu D, Zhang X, Chen Y, Zhu J, Fan A, Ding D, Kong D, Wang Z, Zhao Y (2018a) Multifunctional micelles dually responsive to hypoxia and singlet oxygen: enhanced photodynamic therapy via interactively triggered photosensitizer delivery. ACS Appl Mater Interfaces 10(20):17117–17128. https://doi.org/10.1021/acsami.8b06299
Li M, Xia J, Tian R, Wang J, Fan J, Du J, Long S, Song X, Foley JW, Peng X (2018b) Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors. J Am Chem Soc 140(44):14851–14859. https://doi.org/10.1021/jacs.8b08658
Li J, Shi K, Sabet ZF, Fu W, Zhou H, Xu S, Liu T, You M, Cao M, Xu M, Cui X, Hu B, Liu Y, Chen C (2019) New power of self-assembling carbonic anhydrase inhibitor: short peptide-constructed nanofibers inspire hypoxic cancer therapy. Sci Adv 5(9):eaax0937. https://doi.org/10.1126/sciadv.aax0937
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, Du Y, Li Q, Lou Y, Qiu Y, You J (2019b) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun 10(1):3349. https://doi.org/10.1038/s41467-019-11269-8
Li Y, Ding J, Xu X, Shi R, Saw PE, Wang J, Chung S, Li W, Aljaeid BM, Lee RJ, Tao W, Teng L, Farokhzad OC, Shi J (2020) Dual hypoxia-targeting RNAi nanomedicine for precision cancer therapy. Nano Lett 20(7):4857–4863. https://doi.org/10.1021/acs.nanolett.0c00757
Liu H, Jiang W, Wang Q, Hang L, Wang Y, Wang Y (2019) ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy. Biomater Sci 7(9):3706–3716. https://doi.org/10.1039/c9bm00634f
Liu J, Yang Z, Wang J (2021) Recent advances in peptide-based nanomaterials for targeting hypoxia. Nanoscale Adv. https://doi.org/10.1039/D1NA00637A
Ma D, Huang C, Zheng J, Zhou W, Tang J, Chen W, Li J, Yang R (2019) Azoreductase-responsive nanoprobe for hypoxia-induced mitophagy imaging. Anal Chem 91(2):1360–1367. https://doi.org/10.1021/acs.analchem.8b03492
Mamnoon B, Loganathan J, Confeld MI, De Fonseka N, Feng L, Froberg J, Choi Y, Tuvin DM, Sathish V, Mallik S (2021) Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors. ACS Appl Biomater 4(2):1450–1460. https://doi.org/10.1021/acsabm.0c01336
Milane L, Duan Z, Amiji M (2011) Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. Mol Pharm 8(1):185–203. https://doi.org/10.1021/mp1002653
Nasrolahi Shirazi A, Oh D, Tiwari RK, Sullivan B, Gupta A, Bothun GD, Parang K (2013) Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters. Mol Pharm 10(12):4717–4727.https://doi.org/10.1021/mp400539r
Ou Y, Tang ZH, Sun L, Yu HY, Li J, Zhao MH, Xu H (2018) Combretastatin A4/poly (L-glutamic acid)-graft-PEG conjugates self-assembled to nanoparticles. Asian J Pharm Sci 13(2):191–196. https://doi.org/10.1016/j.ajps.2017.10.001
Park W, Bae BC, Na K (2016) A highly tumor-specific light-triggerable drug carrier responds to hypoxic tumor conditions for effective tumor treatment. Biomaterials 77:227–234. https://doi.org/10.1016/j.biomaterials.2015.11.014
Pearce TR, Shroff K, Kokkoli E (2012) Peptide targeted lipid nanoparticles for anticancer drug delivery. Adv Mater (Deerfield Beach, Fla.), 24(28):3803–3710. https://doi.org/10.1002/adma.201200832
Peng B, Zhao X, Yang MS, Li LL (2019) Intracellular transglutaminase-catalyzed polymerization and assembly for bioimaging of hypoxic neuroblastoma cells. J Mater Chem B 7(37):5626–5632. https://doi.org/10.1039/c9tb01227c
Pethő L, Kasza G, Lajkó E, Láng O, Kőhidai L, Iván B, Mező G (2020) Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity. Soft Matter 16(24):5759–5769. https://doi.org/10.1039/d0sm00428f
Potocky TB, Menon AK, Gellman SH (2005) Effects of conformational stability and geometry of guanidinium display on cell entry by beta-peptides. J Am Chem Soc 127(11):3686–3687. https://doi.org/10.1021/ja042566j
Rudra JS, Sun T, Bird KC, Daniels MD, Gasiorowski JZ, Chong AS, Collier JH (2012) Modulating adaptive immune responses to peptide self-assemblies. ACS Nano 6(2):1557–1564. https://doi.org/10.1021/nn204530r
Semenza GL (2011) Oxygen sensing, homeostasis, and disease. N Engl J Med 365(6):537–547. https://doi.org/10.1056/NEJMra1011165
Shah A, Malik MS, Khan GS, Nosheen E, Iftikhar FJ, Khan FA, Shukla SS, Akhter MS, Kraatz HB, Aminabhavi TM (2018) Stimuli-responsive peptide-based biomaterials as drug delivery systems. Chem Eng J 353:559–583.https://doi.org/10.1016/j.cej.2018.07.126
Shin SW, Jung W, Choi C, Kim SY, Son A, Kim H, Lee N, Park HC (2018) Fucoidan-manganese dioxide nanoparticles potentiate radiation therapy by co-targeting tumor hypoxia and angiogenesis. Mar Drugs 16(12):510. https://doi.org/10.3390/md16120510
Shu Y, Hao T, Yao F, Qian Y, Wang Y, Yang B, Li J, Wang C (2015) RoY peptide-modified chitosan-based hydrogel to improve angiogenesis and cardiac repair under hypoxia. ACS Appl Mater Interfaces 7(12):6505–6517. https://doi.org/10.1021/acsami.5b01234
Soleymani Abyaneh H, Soleimani AH, Vakili MR, Soudy R, Kaur K, Cuda F, Tavassoli A, Lavasanifar A (2018) Modulation of hypoxia-induced chemoresistance to polymeric micellar cisplatin: the effect of ligand modification of micellar carrier versus inhibition of the mediators of drug resistance. Pharmaceutics 10(4):196.https://doi.org/10.3390/pharmaceutics10040196
Song N, Zhao L, Xu X, Zhu M, Liu C, Sun N, Yang J, Shi X, Zhao J (2020) LyP-1-modified multifunctional dendrimers for targeted antitumor and antimetastasis therapy. ACS Appl Mater Interfaces 12(11):12395–12406. https://doi.org/10.1021/acsami.9b18881
Sonju JJ, Dahal A, Singh SS, Jois SD (2021) Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. J Control Release: off J Control Release Soc 329:624–644. https://doi.org/10.1016/j.jconrel.2020.09.055
Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99(Pt A):28–51. https://doi.org/10.1016/j.addr.2015.09.012
Sun H, Dong Y, Feijen J, Zhong Z (2018a) Peptide-decorated polymeric nanomedicines for precision cancer therapy. J Control Release: off J Control Release Soc 290:11–27. https://doi.org/10.1016/j.jconrel.2018.09.029
Sun H, Hong Y, Xi Y, Zou Y, Gao J, Du J (2018b) Synthesis, self-assembly, and biomedical applications of antimicrobial peptide-polymer conjugates. Biomacromol 19(6):1701–1720. https://doi.org/10.1021/acs.biomac.8b00208
Sun XS, Jang MS, Fu Y, Lee JH, Lee DS, Li Y, Yang HY (2020) Intracellular delivery of cytochrome C using hypoxia-responsive polypeptide micelles for efficient cancer therapy. Mater Sci Eng. C, Mater Biol Appl 114:111069. https://doi.org/10.1016/j.msec.2020.111069
Swierczewska M, Han HS, Kim K, Park JH, Lee S (2016) Polysaccharide-based nanoparticles for theranostic nanomedicine. Adv Drug Deliv Rev 99(Pt A):70–84. https://doi.org/10.1016/j.addr.2015.11.015
Taylor PA, Jayaraman A (2020) Molecular modeling and simulations of peptide-polymer conjugates. Annu Rev Chem Biomol Eng 11:257–276. https://doi.org/10.1146/annurev-chembioeng-092319-083243
Teesalu T, Sugahara KN, Ruoslahti E (2013) Tumor-penetrating peptides. Front Oncol 3:216.https://doi.org/10.3389/fonc.2013.00216
Thambi T, Deepagan VG, Yoon HY, Han HS, Kim SH, Son S, Jo DG, Ahn CH, Suh YD, Kim K, Kwon IC, Lee DS, Park JH (2014) Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 35(5):1735–1743. https://doi.org/10.1016/j.biomaterials.2013.11.022
Thambi T, Son S, Lee DS, Park JH (2016) Poly(ethylene glycol)-b-poly(lysine) copolymer bearing nitroaromatics for hypoxia-sensitive drug delivery. Acta Biomater 29:261–270. https://doi.org/10.1016/j.actbio.2015.10.011
Uthaman S, Kim Y, Lee JY, Pillarisetti S, Huh KM, Park IK (2020) Self-quenched polysaccharide nanoparticles with a reactive oxygen species-sensitive cascade for enhanced photodynamic therapy. ACS Appl Mater Interfaces 12(25):28004–28013. https://doi.org/10.1021/acsami.0c06311
Vasconcelos A, Vega E, Pérez Y, Gómara MJ, García ML, Haro I (2015) Conjugation of cell-penetrating peptides with poly (lactic-co-glycolic acid)-polyethylene glycol nanoparticles improve ocular drug delivery. Int J Nanomed 10:609–631. https://doi.org/10.2147/IJN.S71198
Wang J, Shao F, Li W, Yan J, Liu K, Tao P, Masuda T, Zhang A (2017a) Metal-ion-mediated supramolecular assembly of c3 -peptides. Chem Asian J 12(5):497–502. https://doi.org/10.1002/asia.201601721
Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D (2017b) Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy. ACS Nano 11(2):2227–2238. https://doi.org/10.1021/acsnano.6b08731
Wang W, Li X, Wang Z, Zhang J, Dong X, Wu Y, Fang C, Zhou A, Wu Y (2019a) A novel “mosaic-type” nanoparticle for selective drug release targeting hypoxic cancer cells. Nanoscale 11(5):2211–2222. https://doi.org/10.1039/c8nr06452k
Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X (2019b) Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. Int J Nanomed 14:4071–4090. https://doi.org/10.2147/IJN.S194304
Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11(6):393–410. https://doi.org/10.1038/nrc3064
Wong S, Shim MS, Kwon YJ (2014) Synthetically designed peptide-based biomaterials with stimuli-responsive and membrane-active properties for biomedical applications. J Mater Chem B 2(6):595–615. https://doi.org/10.1039/c3tb21344g
Xie JH, Jin ML, Morris GA, Zha XQ, Chen HQ, Yi Y, Li JE, Wang ZJ, Gao J, Nie SP, Shang P, Xie MY (2016) Advances on bioactive polysaccharides from medicinal plants. Crit Rev Food Sci Nutr 56(Suppl 1):S60–S84.https://doi.org/10.1080/10408398.2015.1069255
Xu K, Wang F, Pan X, Liu R, Ma J, Kong F, Tang B (2013) High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor. Chem Commun (camb) 49(25):2554–2556. https://doi.org/10.1039/c3cc38980d
Xu S, Wang Q, Zhang Q, Zhang L, Zuo L, Jiang JD, Hu HY (2017) Real time detection of ESKAPE pathogens by a nitroreductase-triggered fluorescence turn-on probe. Chem Commun (camb) 53(81):11177–11180. https://doi.org/10.1039/c7cc07050k
Yang Z, Cao J, He Y, Yang JH, Kim T, Peng X, Kim JS (2014) Macro-/micro-environment-sensitive chemosensing and biological imaging. Chem Soc Rev 43(13):4563–4601. https://doi.org/10.1039/c4cs00051j
Yang S, Xu D, Dong H (2018) Design and fabrication of reduction-sensitive cell penetrating nanofibers for enhanced drug efficacy. J Mater Chem B 6(44):7179–7184. https://doi.org/10.1039/c8tb00728d
Yang Q, Wang S, Li D, Yuan J, Xu J, Shao S (2020) A mitochondria-targeting nitroreductase fluorescent probe with large Stokes shift and long-wavelength emission for imaging hypoxic status in tumor cells. Anal Chim Acta 1103:202–211. https://doi.org/10.1016/j.aca.2019.12.063
Yao Y, Feng L, Wang Z, Chen H, Tan N (2019) Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoring. Biomater Sci 8(1):256–265. https://doi.org/10.1039/c9bm00905a
Yin W, Qiang M, Ke W, Han Y, Mukerabigwi JF, Ge Z (2018) Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors. Biomaterials 181:360–371. https://doi.org/10.1016/j.biomaterials.2018.08.014
Yu H, Tang Z, Zhang D, Song W, Zhang Y, Yang Y, Ahmad Z, Chen X (2015) Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) complex nanoparticles for tumor therapy. J Control Release: off J Control Release Soc 205:89–97. https://doi.org/10.1016/j.jconrel.2014.12.022
Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, Ligler FS, Buse JB, Gu Z (2017) Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. Nano Lett 17(2):733–739. https://doi.org/10.1021/acs.nanolett.6b03848
Yu-Wai-Man C, Tagalakis AD, Manunta MD, Hart SL, Khaw PT (2016) Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis. Sci Rep 6:21881. https://doi.org/10.1038/srep21881
Zhang S (2017) Discovery and design of self-assembling peptides. Interface Focus 7(6):20170028. https://doi.org/10.1098/rsfs.2017.0028
Zhang D, Qi GB, Zhao YX, Qiao SL, Yang C, Wang H (2015) In Situ formation of nanofibers from purpurin18-peptide conjugates and the assembly induced retention effect in tumor sites. Adv Mater (Deerfield Beach, Fla.) 27(40):6125–6130. https://doi.org/10.1002/adma.201502598
Zhang L, Huang Y, Lindstrom AR, Lin TY, Lam KS, Li Y (2019) Peptide-based materials for cancer immunotherapy. Theranostics 9(25):7807–7825.https://doi.org/10.7150/thno.37194
Zhang P, Yang H, Shen W, Liu W, Chen L, Xiao C (2020a) Hypoxia-responsive polypeptide nanoparticles loaded with doxorubicin for breast cancer therapy. ACS Biomater Sci Eng 6(4):2167–2174. https://doi.org/10.1021/acsbiomaterials.0c00125
Zhang Z, Yang W, Ma F, Ma Q, Zhang B, Zhang Y, Liu Y, Liu H, Hua Y (2020b) Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis. Drug Delivery 27(1):691–702. https://doi.org/10.1080/10717544.2020.1754528
Zhang C, Li Q, Wu C, Wang J, Su M, Deng J (2021) Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy. Nanotechnology 32(9):095107. https://doi.org/10.1088/1361-6528/abcdcc
Zhao J, Li Q, Hao X, Ren X, Guo J, Feng Y, Shi C (2017) Multi-targeting peptides for gene carriers with high transfection efficiency. J Mater Chem B 5(40):8035–8051. https://doi.org/10.1039/c7tb02012k
Zhao C, Tong Y, Li X, Shao L, Chen L, Lu J, Deng X, Wang X, Wu Y (2018) Photosensitive nanoparticles combining vascular-independent intratumor distribution and on-demand oxygen-depot delivery for enhanced cancer photodynamic therapy. Small 14(12):e1703045. https://doi.org/10.1002/smll.201703045
Zhao L, Zou Q, Yan X (2019) Self-assembling peptide-based nanoarchitectonics. Bull Chem Soc Jpn 92(1):70–79. https://doi.org/10.1246/bcsj.20180248
Zhao L, Fu C, Tan L, Li T, Zhong H, Meng X (2020) Advanced nanotechnology for hypoxia-associated antitumor therapy. Nanoscale 12(5):2855–2874. https://doi.org/10.1039/c9nr09071a
Zhen J, Tian S, Liu Q, Zheng C, Zhang, Z., Ding, Y., An, Y., Liu, Y., & Shi, L. (2019). Nanocarriers responsive to a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy. Biomater Sci 7(7):2986–2995.https://doi.org/10.1039/c9bm00461k
Zheng J, Shen Y, Xu Z, Yuan Z, He Y, Wei C, Er M, Yin J, Chen H (2018) Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging. Biosens Bioelectron 119:141–148. https://doi.org/10.1016/j.bios.2018.08.014
Zhou Y, Yang B, Ren X, Liu Z, Deng Z, Chen L, Deng Y, Zhang LM, Yang L (2012) Hyperbranched cationic amylopectin derivatives for gene delivery. Biomaterials 33(18):4731–4740. https://doi.org/10.1016/j.biomaterials.2012.03.014
Zhou Y, Maiti M, Sharma A, Won M, Yu L, Miao LX, Shin J, Podder A, Bobba KN, Han J, Bhuniya S, Kim JS (2018) Azo-based small molecular hypoxia responsive theranostic for tumor-specific imaging and therapy. J Control Release: off J Control Release Soc 288:14–22. https://doi.org/10.1016/j.jconrel.2018.08.036
Zhou H, Qin F, Chen C (2021) Designing hypoxia-responsive nanotheranostic agents for tumor imaging and therapy. Adv Healthcare Mater 10(5):e2001277. https://doi.org/10.1002/adhm.202001277
Zhu C, Zou Z, Huang C, Zheng J, Liu N, Li J, Yang R (2019) Highly selective imaging of lysosomal azoreductase under hypoxia using pH-regulated and target-activated fluorescent nanoprobes. Chem Commun (camb) 55(22):3235–3238. https://doi.org/10.1039/c9cc00462a
Zununi Vahed S, Salehi R, Davaran S, Sharifi S (2017) Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng. C, Mater Biol Appl 71:1327–1341.https://doi.org/10.1016/j.msec.2016.11.073
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumari, P., Sharma, P., Srivastava, Y., Sharma, N.K. (2023). Recent Progress in Hypoxia-Targeting: Peptide-Based Nanomaterials. In: Chawla, S., Singh, S., Husen, A. (eds) Smart Nanomaterials Targeting Pathological Hypoxia. Smart Nanomaterials Technology. Springer, Singapore. https://doi.org/10.1007/978-981-99-1718-1_4
Download citation
DOI: https://doi.org/10.1007/978-981-99-1718-1_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1717-4
Online ISBN: 978-981-99-1718-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)